We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-13.27%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$18.6B
AUM Growth
-$3.22B
Cap. Flow
-$14.7M
Cap. Flow %
-0.08%
Top 10 Hldgs %
18.18%
Holding
3,301
New
145
Increased
1,425
Reduced
1,371
Closed
260

Sector Composition

Rank Sector Weight
1 Technology 9.03%
2 Financials 4.72%
3 Healthcare 4.25%
4 Consumer Discretionary 4.16%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRPX
2976
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$28K ﹤0.01%
67
-2
-3% -$820
SUPV
2977
Grupo Supervielle
SUPV
$738M
$27K ﹤0.01%
20,000
TRX icon
2978
TRX Gold Corp
TRX
$341M
$27K ﹤0.01%
71,300
+26,000
+57% +$8.53K
TRVN
2979
DELISTED
Trevena, Inc.
TRVN
$27K ﹤0.01%
105
+60
+133% +$13.2K
BFX
2980
DELISTED
BowFlex Inc.
BFX
$27K ﹤0.01%
15,343
+3,450
+29% +$9.54K
AREC icon
2981
American Resources Corp
AREC
$302M
$26K ﹤0.01%
+17,930
New +$31.9K
GEVO icon
2982
Gevo
GEVO
$401M
$26K ﹤0.01%
10,920
-10,300
-49% -$37.7K
REFR icon
2983
Research Frontiers
REFR
$15.2M
$26K ﹤0.01%
15,166
DTIL icon
2984
Precision BioSciences
DTIL
$201M
$24K ﹤0.01%
508
-10
-2% -$587
ATHX
2985
DELISTED
Athersys, Inc. Common Stock
ATHX
$23K ﹤0.01%
3,533
MVST icon
2986
Microvast
MVST
$341M
$22K ﹤0.01%
+10,010
New +$43K
ORBS
2987
Eightco Holdings
ORBS
$292M
$22K ﹤0.01%
+43
New +$87.5K
PRTY
2988
DELISTED
Party City Holdco Inc.
PRTY
$22K ﹤0.01%
16,332
-35,100
-68% -$77.6K
ADNWW
2989
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$21K ﹤0.01%
48,500
OGI
2990
Organigram Holdings
OGI
$177M
$21K ﹤0.01%
5,833
+182
+3% +$928
VLDR
2991
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$21K ﹤0.01%
22,036
-60
-0.3% -$104
HUT
2992
Hut 8
HUT
$10.2B
$20K ﹤0.01%
3,002
-2,403
-44% -$35.9K
STAB
2993
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$20K ﹤0.01%
68,825
-1,421
-2% -$367
CRBP icon
2994
Corbus Pharmaceuticals
CRBP
$195M
$19K ﹤0.01%
2,447
-34
-1% -$329
PXLW icon
2995
Pixelworks
PXLW
$45.7M
$19K ﹤0.01%
+847
New +$21.9K
ZTEK
2996
Zentek
ZTEK
$80.3M
$19K ﹤0.01%
10,500
OIG
2997
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$19K ﹤0.01%
737
GLMD icon
2998
Galmed Pharmaceuticals
GLMD
$4.39M
$18K ﹤0.01%
151
+6
+4% +$994
SENS icon
2999
Senseonics Holdings Inc
SENS
$409M
$18K ﹤0.01%
866
TCRT icon
3000
Alaunos Therapeutics
TCRT
$4.86M
$18K ﹤0.01%
+95
New +$9.08K

Similar funds

Cambridge Investment Research Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Cambridge Investment Research Advisors held 3,301 positions worth $18.6B, down 15% from $21.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2022 filing shows 145 new, 1,425 increased, 1,371 reduced and 260 closed positions. Its largest new stake was Simplify US Equity PLUS Downside Convexity ETF: 863,983 shares worth $22.9M. The largest sale was Invesco QQQ Trust, an estimated $84.3M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2022 buy was Simplify US Equity PLUS Downside Convexity ETF: 863,983 shares worth $22.9M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2022, an estimated $82M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $84.3M.
  • Cambridge Investment Research Advisors fully exited State Street SPDR Bloomberg International Treasury Bond ETF in Q2 2022, selling an estimated $18M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $18.6B portfolio in Q2 2022.
  • Cambridge Investment Research Advisors opened 145 new positions and closed 260 in Q2 2022.
  • Cambridge Investment Research Advisors's portfolio value fell 15% quarter-over-quarter to $18.6B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.